Report cover image

Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Publisher GlobalData
Published Sep 29, 2023
Length 115 Pages
SKU # GBDT18272403

Description

Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Glaucoma Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Glaucoma Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

115 Pages
    • Glaucoma Surgery Devices Overview
    • Glaucoma Surgery Devices - Pipeline Products by Stage of Development
    • Glaucoma Surgery Devices - Pipeline Products by Segment
    • Glaucoma Surgery Devices - Pipeline Products by Territory
    • Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
    • Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
    • Glaucoma Surgery Devices - Ongoing Clinical Trials
    • Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
    • Glaucoma Surgery Devices - Companies Pipeline Products by Stage of Development
    • Alievio Inc Company Overview
    • Allergan Ltd Company Overview
    • Assenti, LLC Company Overview
    • Avisi Technologies LLC Company Overview
    • Chongqing Migos Medical Technology Co Ltd Company Overview
    • Ciliatech Therapeutics AG Company Overview
    • Corneat Vision Ltd Company Overview
    • Eye Sonix Company Overview
    • Galaxy Ophthalmics Inc (Inactive) Company Overview
    • Geuder AG Company Overview
    • Glaucot Teknoloji AS Company Overview
    • Glaukos Corp Company Overview
    • HiSilicon (Suzhou) Biomedical Technology Co Ltd Company Overview
    • Iantrek Inc Company Overview
    • InjectSense Inc Company Overview
    • InnFocus Inc Company Overview
    • iScience Interventional Inc Company Overview
    • iSTAR Medical SA Company Overview
    • iVeena Delivery Systems Inc Company Overview
    • Johns Hopkins University Company Overview
    • Kytogenics Pharmaceuticals Inc Company Overview
    • Liqid Medical (Pty) Ltd Company Overview
    • Medtronic Plc Company Overview
    • Meir Medical Center Company Overview
    • Merz Anteis SA Company Overview
    • MicroOptx Inc Company Overview
    • Mingche Biotechnology (Suzhou) Co Ltd Company Overview
    • Myra Vision Inc Company Overview
    • Ocumatrx Company Overview
    • OcuTherix Inc Company Overview
    • OPKO Health Inc Company Overview
    • OptoLight Vision Technology Company Overview
    • Purdue University Company Overview
    • Queen's University Company Overview
    • Rheon Medical SA Company Overview
    • Sight Sciences Inc Company Overview
    • Tel Aviv University Company Overview
    • The Chaim Sheba Medical Center Company Overview
    • University of Colorado Company Overview
    • University of Colorado Anschutz Medical Campus Company Overview
    • University of Michigan Company Overview
    • University of Texas at Austin Company Overview
    • Westhouse Medical Services Plc (Inactive) Company Overview
    • Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
    • Aug 15, 2023: Alcon Reports Second Quarter 2023 Results
    • Jul 12, 2023: Ocular Therapeutix Announces Appointment of New Board Member
    • May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
    • May 08, 2023: Ocular Therapeutix provides first quarter 2023 financial results and corporate update
    • Apr 25, 2023: OPKO Health to report Q1 2023 financial results on May 3, 2023
    • Apr 12, 2023: Medtronic has a layoff in California
    • Mar 29, 2023: STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
    • Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
    • Feb 21, 2023: Ocular Therapeutix To Report Fourth Quarter and Year-End 2022 Financial Results
    • Feb 16, 2023: OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
    • Feb 01, 2023: Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22
    • Jan 09, 2023: STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
    • Jan 09, 2023: New high-tech startup developing smart contact lenses for glaucoma diagnosis and management
    • Jan 04, 2023: Verana Health and Sight Sciences collaborate on glaucoma research using curated realworld data from the IRIS registry
    • Dec 21, 2022: Wilmington Eye ophthalmic surgeon implants first-ever glaucoma device in the Carolinas
    • Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • Nov 15, 2022: ViaLase Strengthens Executive Team with the Appointments of Tom Frinzi as Executive Chairman of the Board Richard Lewis M.D. as Chief Medical Officer and Shawn O'Neil as Chief Commercial Officer
    • Nov 08, 2022: Zhaoke Ophthalmology : Reaching exclusive distribution agreement to commercialize TONO-i in greater China for self-measurement of intraocular pressure
    • Oct 24, 2022: Ocular Therapeutix To Report Third Quarter 2022 Financial Results
    • Sep 28, 2022: Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting
    • Sep 22, 2022: Ocular Therapeutix To Present Data at the American Academy of Ophthalmology 2022 Annual Meeting
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.